Press
·
News
P+P advised Dermapharm AG on acquisition of Trommsdorff GmbH & Co. KG
Dermapharm AG, headquartered in Grünwald, concentrates on manufacturing and marketing high-quality dermatological and allergological pharmaceuticals.
Trommsdorff GmbH & Co. KG, based in Alsdorf, Germany, is a medium-sized pharmaceutical company that manufactures and develops galenicals and also markets pharmaceuticals, dietary supplements and supplementary balanced diets. Trommsdorff also distributes medical products.
P+P Pöllath + Partners advised Dermapharm AG on the aquisition with the following team:
- Dr. Matthias Bruse (partner, private equity/M&A, Munich)
- Dr. Nico Fischer (partner, tax, Munich)
- Daniel Wiedmann (counsel, antitrust, Frankfurt)
- Dr. Matthias Werner (counsel, real estate, Berlin)
- Susanne Bitzinger (senior associate, tax, Munich)
- Philipp Kopp (associate, private equity/M&A, Munich)
- Thies Jacob (associate, private equity/M&A, Munich)
